Cigarette smoking is at all-time lows globally, but the use of
electronic cigarettes has increased profoundly. Recent reports of
electronic cigarette or vaping use-associated lung injury may lead
individuals to explore novel methods of nicotine consumption, such as
heat-not-burn devices. IQOS from Philip Morris, a heat-not-burn device,
became available for purchase in the United States in October 2019.
Philip Morris claims that 8.8 million people have abandoned traditional
cigarettes in favor of IQOS; however, evidence suggests that it may act
as a gateway or complement to cigarette smoking, rather than a
replacement.To get more news about
HNB, you can visit hitaste.net official website.
Surveys indicate that 96% of Korean IQOS users also smoke cigarettes,
and 45% of Italian users of IQOS had never smoked cigarettes. In the
United States, Canada, and England, susceptibility of youth to trying
IQOS was slightly lower than electronic cigarettes, but higher than
cigarette smoking. Heat-not-burn products produce mainstream and
second-hand emissions of harmful chemicals, including nicotine,
particulate matter, benzene, acrolein, and tobacco-specific
nitrosamines. The levels of these emissions, despite being less than
those of traditional cigarettes, are potentially harmful to
cardiovascular health. A study of current smokers showed similar acute
effects of heat-not-burn tobacco products and traditional cigarettes on
heart rate, blood pressure, and arterial stiffness. Rats exposed to IQOS
had similar vascular endothelial function impairment to those exposed
to cigarettes. Heat-not-burn aerosol exposure of cultured macrophages
elicited increased oxidative stress, although less than that induced by
cigarette smoke. Further studies are needed to better understand the
cardiovascular effects of heat-not-burn tobacco products.
The Wall